CRUCIBLE THERAPEUTICS LIMITED
Research and experimental development on biotechnology
CRUCIBLE THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
The Innovation Centre 217 Portobello Sheffield S1 4DP England
Full company profile for CRUCIBLE THERAPEUTICS LIMITED (14690230), an active company based in Sheffield, England. Incorporated 27 Feb 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Cash in Bank
£1.26M
Net Assets
£1.05M
Total Liabilities
£279.77k
Turnover
N/A
Employees
N/A
Debt Ratio
21%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 28 Feb Year End | 2024 29 Feb Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Gibbons, James William | Director | British | England | 17 Oct 2024 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Northern Gritstone Limited
United Kingdom
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Argobio S.a.s.
France
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Professor Guillaume Marcel Pierre Hautbergue
Ceased 21 Sept 2023
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 17 Apr 2026 | Confirmation Statement | Confirmation statement made on 5 Apr 2026 with no updates | |
| 7 Nov 2025 | Accounts | Annual accounts made up to 28 Feb 2025 | |
| 14 Aug 2025 | Officers | Termination of Ross Alexander Mcmaster as director on 23 Jul 2025 | |
| 14 Aug 2025 | Officers | Appointment of Dr Samantha Jane Macro as director on 23 Jul 2025 | |
| 17 Apr 2025 | Capital | Allotment of shares (GBP 3) on 10 Mar 2025 |
Confirmation statement made on 5 Apr 2026 with no updates
Annual accounts made up to 28 Feb 2025
Termination of Ross Alexander Mcmaster as director on 23 Jul 2025
Appointment of Dr Samantha Jane Macro as director on 23 Jul 2025
Allotment of shares (GBP 3) on 10 Mar 2025
Recent Activity
Latest Activity
Confirmation statement made on 5 Apr 2026 with no updates
1 months ago on 17 Apr 2026
Annual accounts made up to 28 Feb 2025
6 months ago on 7 Nov 2025
Termination of Ross Alexander Mcmaster as director on 23 Jul 2025
9 months ago on 14 Aug 2025
Appointment of Dr Samantha Jane Macro as director on 23 Jul 2025
9 months ago on 14 Aug 2025
Allotment of shares (GBP 3) on 10 Mar 2025
1 years ago on 17 Apr 2025